0001567619-19-020108.txt : 20191029 0001567619-19-020108.hdr.sgml : 20191029 20191029133325 ACCESSION NUMBER: 0001567619-19-020108 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191029 DATE AS OF CHANGE: 20191029 EFFECTIVENESS DATE: 20191029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Engage Therapeutics, Inc. CENTRAL INDEX KEY: 0001719075 IRS NUMBER: 820610340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-352070 FILM NUMBER: 191175777 BUSINESS ADDRESS: STREET 1: 31 LENOX ROAD CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: 215-696-9659 MAIL ADDRESS: STREET 1: 31 LENOX ROAD CITY: SUMMIT STATE: NJ ZIP: 07901 D 1 primary_doc.xml X0708 D LIVE 0001719075 Engage Therapeutics, Inc. 31 LENOX ROAD SUMMIT NJ NEW JERSEY 07901 215-696-9659 DELAWARE None None Corporation true 2016 Gregory Mayes 31 Lenox Road Summit NJ NEW JERSEY 07901 Executive Officer Director Promoter Warren Lammert 109 State Street, 5th Floor Boston MA MASSACHUSETTS 02109 Director Orrin Devinsky 223 East 34th Street New York NY NEW YORK 10016 Director Stephen Collins 508 Ryan Place Lake Forest IL ILLINOIS 60045 Director Heath Lukatch 301 Commerce Street, Suite 300 Fort Worth TX TEXAS 76102 Director Gerry Brunk 304 Highland Street Weston MA MASSACHUSETTS 02493 Director Jouko Isojarvi 610 Swift Creek Crossing Durham NC NORTH CAROLINA 27713 Executive Officer Mark Theeuwes 31 Lenox Road Summit NJ NEW JERSEY 07901 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2019-10-18 false true true false 0 12000000 6999999 5000001 false 18 0 0 0 false Engage Therapeutics, Inc. Gregory Mayes Gregory Mayes Chief Executive Officer 2019-10-29